PSVT: Exploring Treatment Options for Paroxysmal Supraventricular Tachycardia

Join Alison Stephens, PA-C, as she defines PSVT (paroxysmal supraventricular tachycardia), explores its impact on patients' quality of life, and discusses various treatment options, including a new FDA-approved nasal spray.

CE units are available for this episode only through June 15, 2027. To access CE, visit pcna.net/course/spotlight-on-psvt/.

Related PCNA Resources:

​​- Patient Journey: PSVT Strikes Anytime, Anyplace - https://pcna.net/resource/patient-journey-psvt-strikes-anytime-anyplace-video/

​- PSVT: Barriers and Solutions to the Disease Burden for Patients - https://pcna.net/resource/psvt-barriers-and-solutions-to-the-disease-burden-for-patients/

- Living with PSVT: A Patient-Centered Care Plan ​- Living with PSVT: Episodic Rapid Heart Rates - https://pcna.net/podcast/living-with-psvt-a-patient-centered-care-plan/

Related Episode Resources:

- Self-Administered Etripamil and Emergency Department Visits in Supraventricular Tachycardia - https://jamanetwork.com/journals/jamacardiology/fullarticle/2832045

- Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial - https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00776-6/fulltext

- Catheter Ablation of Atypical Atrioventricular Nodal Reentrant Tachycardia - https://pubmed.ncbi.nlm.nih.gov/27754882/

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.